Clinical Trials Directory

Trials / Unknown

UnknownNCT04325412

Cardiac complicAtions in Patients With SARS Corona vIrus 2 (COVID-19) regisTrY

Cardiac complicAtions in Patients With SARS Corona vIrus 2 regisTrY

Status
Unknown
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
UMC Utrecht · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

CAPACITY (www.capacity-covid.eu) is a registry of patients with COVID-19 across Europe and has been established to answer questions on the role of cardiovascular disease in this pandemic. It is an extension of the Case Record Form (CRF) that was released by the ISARIC (International Severe Acute Respiratory and Emerging Infection Consortium) and WHO (World Health Organisation) in response to the emerging outbreak of COVID-19.

Detailed description

The aim of CAPACITY is to collect data regarding the cardiovascular history, diagnostic information and occurrence of cardiovascular complications in COVID-19 patients. By collecting this information in a standardized manner, CAPACITY can aid in providing more insight in (1) the incidence of cardiovascular complications in patients with COVID-19, and (2) the vulnerability and clinical course of COVID-19 in patients with an underlying cardiovascular disease. The CAPACITY extension to the ISARIC-WHO CRF consists of additional data collection instruments for: * cardiac history and cardiovascular risk factors * prior use of cardiac medication or NSAIDs * electrocardiography (ECG) * echocardiography * cardiac MRI * invasive cardiac procedures * cardiac complications * cardiac biomarkers * cardiac outcome during admission

Conditions

Timeline

Start date
2020-03-23
Primary completion
2021-03-23
Completion
2021-06-23
First posted
2020-03-27
Last updated
2020-11-10

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT04325412. Inclusion in this directory is not an endorsement.